Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : People symbols : SNYNF save search
OMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmann
Published: 2024-04-08 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
therapeutics
Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
therapeutics
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
financial
Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
Baisong Mei’s Immigrant Journey Through American Biopharma
Published: 2024-02-29 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
biopharma
C-Suite Shuffle: ReNAgade, Adaptimmune, Vittoria and More
Published: 2024-02-28 (Crawled : 18:00) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.12%
H: 0.52%
C: 0.47%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer
Published: 2024-02-28 (Crawled : 15:30) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
medical
Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer
Published: 2024-02-01 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
medical therapeutics
Abdera Therapeutics Expands Management Team and Board of Directors
Published: 2024-01-30 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
management therapeutics
BioCT Welcomes Accomplished Life Science Executives to Board of Directors
Published: 2024-01-10 (Crawled : 14:00) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
life
Akebia Therapeutics Announces Appointment of Nicholas Grund as Chief Commercial Officer
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: -1.89%
commercial therapeutics
Curapath Appoints Philippe Clavel as Chief Executive Officer
Published: 2023-12-13 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
Electra Therapeutics Appoints Kathy Dong, PharmD, MBA, as President and Chief Executive Officer
Published: 2023-12-11 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
therapeutics
3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic
Published: 2023-10-25 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.4%
H: 1.29%
C: 1.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.43%
H: 0.64%
C: -0.09%
OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
Published: 2023-09-26 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.39%
H: 0.23%
C: 0.23%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
therapeutics
Accent Therapeutics Bolsters Leadership Team with Key Executive Hires
Published: 2023-09-21 (Crawled : 14:30) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
therapeutics
Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer
Published: 2023-09-12 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
business therapeutics
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
Published: 2023-09-01 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
biopharma
Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman
Published: 2023-08-29 (Crawled : 10:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
ceo therapeutics
Genprex Appoints Suzanne Thornton-Jones as Senior Vice President, Regulatory Affairs
Published: 2023-08-22 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: -2.58%
H: 14.23%
C: 10.72%